药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Carbetocin
9-Methylguanine
The serum concentration of 9-Methylguanine can be decreased when it is combined with Teriflunomide.
Carbetocin
Xanthine
The serum concentration of Xanthine can be decreased when it is combined with Teriflunomide.
Carbetocin
8-azaguanine
The serum concentration of 8-azaguanine can be decreased when it is combined with Teriflunomide.
Carbetocin
Etoricoxib
The serum concentration of Etoricoxib can be decreased when it is combined with Teriflunomide.
Carbetocin
Bromazepam
The serum concentration of Bromazepam can be decreased when it is combined with Teriflunomide.
Carbetocin
Fenethylline
The serum concentration of Fenethylline can be decreased when it is combined with Teriflunomide.
Carbetocin
Theobromine
The serum concentration of Theobromine can be decreased when it is combined with Teriflunomide.
Carbetocin
Temafloxacin
The serum concentration of Temafloxacin can be decreased when it is combined with Teriflunomide.
Carbetocin
Rasagiline
The serum concentration of Rasagiline can be decreased when it is combined with Teriflunomide.
Carbetocin
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Teriflunomide.
Carbetocin
Roflumilast
Roflumilast may increase the immunosuppressive activities of Teriflunomide.
Carbetocin
Difluocortolone
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Difluocortolone.
Carbetocin
Clobetasol
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Clobetasol.
Carbetocin
Fluocortolone
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Fluocortolone.
Carbetocin
Hydrocortisone butyrate
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Hydrocortisone butyrate.
Carbetocin
Bleselumab
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Bleselumab.
Carbetocin
Rozanolixizumab
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Rozanolixizumab.
Carbetocin
Risankizumab
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Risankizumab.
Carbetocin
Emapalumab
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Emapalumab.
Carbetocin
Hydrocortisone succinate
The risk or severity of adverse effects can be increased when Teriflunomide is combined with Hydrocortisone succinate.